SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-23-124356
Filing Date
2023-04-28
Accepted
2023-04-28 07:52:53
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-04-28

Document Format Files

Seq Description Document Type Size
1 ARS d441147dars.pdf ARS 1650128
  Complete submission text file 0001193125-23-124356.txt   2273934
Mailing Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215 (978) 501-3026
Verve Therapeutics, Inc. (Filer) CIK: 0001840574 (see all company filings)

IRS No.: 824800132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-40489 | Film No.: 23860235
SIC: 2834 Pharmaceutical Preparations